Rectal Cancer
A Randomized, Active-Controlled, Double-blind, Multicenter, Phase 3 Clinical Study of Ivonescimab in Combination with FOLFOX versus Bevacizumab in Combination with FOLFOX for the First-line Treatment of Metastatic Colorectal Cancer (HARMONi-GI3) SMT112-3005
- Details
ClinicalTrials.gov ID:
NCT07228832
Diagnosis Type:
NA
USOR Number:
- Address
,
P: